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ABSTRACT 
Bioanalysis is an essential part in drug discovery and development. Bioanalysis is related to the analysis of analytes (drugs, metabolites, 
biomarkers) in biological samples and it involves several steps from sample collection to sample analysis and data reporting.  The first step is 
sample collection from clinical or preclinical studies; then sending the samples to laboratory for analysis.  Second step is sample preparation 
and it is very important step in bioanalysis. In order to reach reliable results, a robust and stable sample preparation method should be applied. 
The role of sample preparation is to remove interferences from sample matrix and improve analytical system performance. Sample preparation 
is often labour intensive and time consuming. This guideline defines key elements necessary for the validation of bioanalytical methods. The 
guideline focuses on the validation of the bioanalytical methods generating quantitative concentration data used for pharmacokinetic and 
toxicokinetic parameter determinations. Guidance and criteria are given on the application of these validated methods in the routine analysis of 
study samples from animal and human studies. Measurement of drug concentrations in biological matrices (such as serum, plasma, blood, 
urine, and saliva) is an important aspect of medicinal product development. It is therefore paramount that the applied bioanalytical methods 
used are well characterised, fully validated and documented to a satisfactory standard in order to yield reliable results. This review provides an 
overview of bioanalytical method development and validation and main principles of method validation stages discussed.  
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INTRODUCTION   
Measurement of drug concentrations in biological matrix 
(such as serum, plasma, blood, urine, and saliva) is an 
essential aspect of medicinal product development. Such 
data may be required to support applications for new actives 
substances and generics as well as variation to authorised 
drug products. The results of animal toxicokinetic studies 
and of clinical trials, including bioequivalence studies are 
used to make significant decisions supporting the safety and 
efficacy of a medicinal drug substance or product. 
Bioanalysis is not only measuring of small molecules such as 
drugs and metabolites but also to identify large molecules 
such as proteins and peptides. Bioanalysis is well established 
in pharmaceutical companies to support drug discovery and 
drug development. Bioanalysis has an important role to 
perform the toxicokinetic (TK), pharmacokinetic (PK) and 
pharmacodynamics (PD) studies of new drugs. It is therefore 
principle that the applied bioanalytical methods used are 
well characterised, fully validated and documented to a 
satisfactory standard in order to yield reliable results. A bio-
analytical method is a set of all of the procedures involved in 
the collection, processing, storage or storing and analysis of 
a biological matrix for an analyte. Analytical methods 
employed for quantitative determination of drugs and their 
metabolites in biological fluids are the key determinants in 
generating reproducible and reliable data that in turn are 
used in the evaluation and interpretation of bioavailability, 
bioequivalence and pharmacokinetics. Method development 
is a scientific procedure. It involves evaluation and 
optimization of the various stages of sample preparation, 
chromatographic conditions, detection and quantification. 
[1-10] 
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The bioanalysis procedure includes sampling, sample 
preparation, analysis, calibration and data evaluation and 
reporting (Fig.1). In modern bioanalysis a good sample 
preparation and a hyphenated instrumentation are required. 
In pharmaceutical research companies the development of 
comprehensive bioanalytical methods is very important 
during the process of drug discovery and development. In 
addition the method validation has an important role in 
regulatory bioanalysis to ensure the quality of the applied 
method. Bioanalytical method validation is very important 
for supporting of new drug applications or biologics license 
applications. 
The present review provides critical points to consider when 
carrying out bioanalytical method development and 
validation. Until now, different publications have been 
published with method validation trends but still lack of 
concise and comprehensive review for method validation 
providing specific requirements for conducting GLP 
nonclinical and clinical study sample analysis. In this paper 
required information for bioanalytical method development 
and method validation according to GLP guidelines will be 
presented. [1-12]  
 
 
Figure N1:- Bioanalysis Procedure 
 
Need of Bioanalytical Method Validation 
 It is essential to used well-characterized and fully 
validated Bioanalytical methods to yield reliable 
results that can be satisfactorily interpreted.  
 It is recognized that Bioanalytical methods and 
techniques are constantly undergoing changes and 
improvements; they are at the cutting edge of the 
technology.  
 It is also important to emphasize that each 
Bioanalytical technique has its own characteristics, 
which will vary from analyte to analyte, specific 
validation criteria may need to be developed for each 
analyte.  
 Moreover, the appropriateness of the technique may 
also be influenced by the ultimate objective of the 
study. When sample analysis for a given study is 
conducted at more than one site, it is necessary to 
validate the Bioanalytical method(s) at each site and 
provide appropriate validation information for 
different sites to establish inter-laboratory reliability. 
Bio-analytical Method Development 
A bio-analytical method is a set of all of the procedures 
involved in the collection, processing, storage or storing and 
analysis of a biological matrix for an analyte. Analytical 
methods working for quantitative determination of drugs 
and their metabolites in biological fluids are the key 
determinants in generating reproducible and dependable 
data that in turn are used in the evaluation and elucidation of 
bioavailability, bioequivalence and pharmacokinetics. 
Method development is a scientific procedure. It involves 
evaluation and optimization of the various stages of sample 
preparation, chromatographic conditions, detection and 
quantification. 
Separation and Detection by RP-HPLC 
High performance liquid chromatography (HPLC) is a 
powerful technique in bioanalysis. HPLC columns have a 
wide range of selectivity and therefore HPLC was applied for 
the separation of many drugs and metabolites in different 
matrices. The main type of detectors used in HPLC is UV-vis. 
HPLC-UV was applied for separation and determination of 
various analytes and matrices. UV detector is cost effective 
but can be used only for high analyte concentration (µM 
range), for small sample volumes and low concentration 
levels (nM, pM) the mass spectrometry is most useful 
detector. [14-18]    
In bio-analytical method development various activities 
are carried out. Stages involved in method development 
using RP- HPLC are as follows: 
 Literature search for drugs. 
 Identification of analytical technique and optimization  
 Reference standard preparation 
 Selection and optimization of extraction method 
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Literature Search for Drugs. 
 
Figure 2:- Literature Search for Drugs 
Selection of Appropriate Column and Mobile Phase:- 
 Mode of separation 
 Selection of appropriate column 
 Mobile phase 
 Role of pH, Buffer  
  Role of Temperature  
  Role of flow rate  
Established Extraction Techniques in Drug Bioanalysis  
Sample clean-up (sample preparation) is a primarily step 
before injection of complex matrices such as plasma, blood, 
urine and tissue into the analytical instruments. Regularly 
used sample preparation methods in many bioanalytical 
laboratories are protein precipitation (PPT), Liquid-liquid 
extraction (LLE), solid phase extraction (SPE). In the 
following sections the main sample preparation techniques 
will be discussed 
1. Liquid-liquid extraction (LLE)  
LLE is still an smart technique in sample preparation and it 
has been extensively used for the preparation of aqueous 
and biological samples. Basically, in liquid-liquid extraction 
an aqueous sample (e.g., plasma, urine) and an immiscible 
organic solvent are mixed to eliminate the analyte into the 
organic phase for injection into an analytical system. This 
method can provide good recovery and clean sample. LLE 
was used for the extraction of basic and acidic drugs from 
biological samples with high extraction recovery. 
2. Solid phase extraction (SPE)  
At the present time, SPE is the most well-known sample 
preparation method due to the high efficiency, cost-effective, 
high-reproducibility, relatively green and easy to operate 
and automate. SPE is beneficial such as separating and 
concentrating of trace analytes in biological samples. SPE is a 
straight forward method that uses a sorbent of 50–200 mg 
as cartridge to separate required analytes from a complex 
matrix. Recently, other formats of SPE have also been 
developed such as, flat disks and μ SPE. The nature and 
amount of the sorbent, loaded sample volume (with enough 
recovery), composition and volume of the washing and 
elution solutions (without loss of the analytes) are the 
effective parameters in SPE performance. 
Solid Phase Extraction types and mechanism:    
A- Reversed-phase,  
Reverse Phase-SPE, (polar sample matrix includes nonpolar 
analytes using nonpolar sorbent). The used sorbents in this 
type are bonded silica (C4, C8, C18 and Ph, with 40 μm 
particle size and 60Å pore size) and polymer sorbent as 
polystyrene can be used. In general the analytes are 
intermediate polar to nonpolar and hydrophobic 
interactions between analytes and nonpolar sorbent 
material occurred. This type of SPE is less selective 
compared to normal phase or ion-exchange SPE. The used 
elution solutions in RP-SPE are methanol, acetonitrile or 
mixed buffer/solvent. Typical applications in RP-SPE are 
drugs in biological fluids and environmental pollutants in 
water.  
B- Normal-phase  
Normal Phase- SPE (polar analytes in nonpolar matrices 
using polar sorbents). Typical sorbents in NP-SPE are silica 
with polar functional groups (Si-CN, Si-NH2, Si-Diol and 
pure silica). In NP, the retention mechanism is based on 
hydrogen bonding between analytes and sorbent.   
C- Ion exchange (anion and cation-exchange)  
SPE, for charged analytes in sample solution. Based on this 
method the anionic analytes (acidic drugs) can be isolated 
with quaternary amine bonded silica or Si-NH2 as anion 
exchange. For basic drugs, strong cation exchange, Si-SCX 
(propylsulfonic acid bonded) and week cation exchange, Si 
WCX (carboxy propyl phase) can be used for isolating the 
cationic analytes (basic drugs). Sulfonic acid bonded silica 
with Na+ counter ion and carboxylic acid-bonded silica with 
Na+ counter ion are common sorbents for SCX and WCX, 
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3. Protein precipitation (PPT)  
Precipitation is broadly applied for product recovery of 
biomolecules particularly proteins. Protein precipitation is 
appropriate for plasma or blood samples especially at high 
analyte concentration. Precipitation is generally induced by 
addition of a miscible organic solvent (acetonitrile, acetone 
or methanol), salt (aluminium chloride), metal ions (zinc 
sulphate) or by changing the sample pH to alter the nature of 
the solution (acids such as trichloroacetic, perchloric, met 
phosphoric and tungstic). Protein precipitation as a fast and 
simple extraction approach can be applied for both 
hydrophilic and hydrophobic compounds. In some cases (for 
extraction of some drugs and metabolites) the protein 
precipitation method can be followed by LLE or SPE in order 
to achieve higher efficiency. 
4. Microextraction techniques  
The use of microextraction techniques in bioanalysis has 
been gained attraction due to achieve high throughput 
sample preparation, to handle small sample volumes and to 
decrease solvents consuming. Last two decades new 
microextraction techniques such as solid-phase 
microextraction (SPME), stir-bar sorptive extraction (SBSE), 
microextraction by packed sorbent (MEPS) and packed tips 
were introduced in bioanalysis. 
4.1. Solid phase microextraction (SPME)  
SPME was introduced in the year of 1989 and has been 
accepted as a powerful solvent-free extraction technique 
especially for GC. SPME has been accepted as a straight 
forward and automated method in environmental analysis 
and lesser amount in bioanalysis. Commonly in SPME, a 
fused silica fiber is coated with a stationary phase. The 
equilibrium in SPME is established by exposing fiber with 
the analyte in matrix. SPME has two general sorts; direct 
extraction of analytes with concentration of the fiber into the 
sample, or utilizing headspace to extract volatile compounds 
from fiber surface which are partitioned between gaseous 
and liquid phases. To have an efficient SPME process some 
parameters such as; temperature, pH, salt concentration, 
stirring rate, the equilibrium constant and equilibration time 
need to be optimized. SPME is a practical technique but still 
suffering from some drawbacks such as; short fiber lifetime 
and low sensitivity of analytes in complex matrices.  
4.2. Stir bar Sorptive extraction (SBSE)  
Stir bar sorptive extraction (SBSE) was introduced in the 
year of 1999 by Sandra et al. and based on the similar 
principle of SPME. In this technique, a magnetic stirring bar 
of quartz coated with polydimethylsiloxane (PDMS) is used. 
Compared to SPME the SBSE has more coated polymer (>50 
times) and so higher extraction efficiency is obtained using 
SBSE compared to SPME. SBSE is cost effective technique 
and it is commonly used in environmental applications but it 
was also applied in bioanalysis for the extraction of some 
drugs and metabolites from biological fluids.   
4.3. Microextraction by packed sorbent (MEPS)  
MEPS was invented in 2004 as a novel, simple, fast, cost-
effective, readily automated and green samples preparation 
method. MEPS is µ-SPE technique that can be connected on-
line to GC or LC systems. In MEPS the sorbent is fitted in a 
liquid handling microsyringe as a plug with low-void-
volume. When the sample is drawn through the syringe, the 
analytes are adsorbed onto the solid phase. The sorbent then 
is washed with water and finally the analytes were absorbed 
by suitable solvent.  
Microextraction packed sorbent steps are similar to SPE and 
needs to consider some solutions (based on the analyte 
structure and polarity) for conditioning (100-200 µL acidic 
water with a small amount of solvent such as methanol 
(20%), loading (4×100 µL), washing (100 μL of 0.1% formic 
acid in water or with 5% methanol in water) and eluting (20 
to 50 μL methanol or acetonitrile) sections. Different sorts of 
sorbents can be used in MEPS such as; C18, C8, C2, C8/SCX, 
SCX, SAX, imprinted polymers and silica. MEPS has been 
applied for determination of different drugs and metabolites 
in different types of biological fluids. 
4.4. Packed tips  
Recently, the packed sorbents (silica and monolithic based 
sorbents, imprinted polymers) in a single tip or 96-tips 
(monolithic) have been developed with great efficiency and 
selectivity in bioanalysis. The extraction steps and process 
are almost similar to SPE and MEPS. Monolithic packed 96-
tips is a clean, fast, high-throughput and semi-automated 
sample preparation and can handle small sample volumes. 
[13] 
Table 1. Bioanalytical method development and 
validation strategies 
Subject Requirements / Activity 
Analyte 
 Chemical structure 
 Chemical properties 
 Analyte purity 
Sample 
preparation 
 Nature and property of the matrix 
 Matrix stability 
 Choose of suitable extraction method 
 Extraction recovery 
Method 
validation 




 Matrix effect 
 Carry-over 
 Stability (short and long term) 
 Bio-Analytical Method Validation  
Method validation can be defined as “Establishing 
documented evidences, which provides a high degree of 
assurance that a specific method or activity will consistently 
produce a desired result or product meeting its 
predetermined specifications and quality characteristics”. 
Bio- analytical method validation includes all of the 
procedures that demonstrate that a particular method used 
for quantitative measurement of analyte in a given biological 
matrix, such as blood, plasma, serum and urine is reliable 
and reproducible for the intended use. 
Types of Method Validation  
Full Validation 
Full validation is important when developing and 
implementing a bio-analytical method for the first time and 
is also important for a new drug entity. A full validation of 
the revised assay is important if metabolites are added to an 
existing assay for quantification. 
Partial Validation 
Partial validation is modification of already validated bio-
analytical method. Partial validation can range from as 
minute as one intra-assay accuracy and precision 
determination to a practically full validation. 
Classic bio-analytical method changes that drop into this 
category include, 
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• Change in analytical methodology (e.g. change in 
detection systems) 
• Change in sample process in procedures 
• Change in anticoagulant in harvesting biological fluid 
• Change in matrix within species (e.g. human plasma to 
human urine) or 
• Change in species within matrix (e.g. rat plasma to 
mouse plasma) 
• Change in relevant concentration range 
Selectivity demonstration of an analytes in the presence of 
concomitant medications or of specific metabolites. 
Cross Validation 
Cross-validation is a comparison of validation parameters 
when two or more bio-analytical methods are used to 
generate data within the same study or across different 
studies. An example of cross validation would be a situation 
where an original validated bio-analytical method serves as 
the reference and the revised bio-analytical method is the 
comparator.  When sample analysis within a single study are 
conducted at more than one site or more than one 
laboratory, cross validation with spiked matrix standards 
and subject samples should be conducted at each site or 
laboratory to create inter laboratory reliability.[19] 
Various Parameters involved in validation 
 Linearity 
 Accuracy & Precision 
A. Precision Intra-day or within batch 
B. Precision Inter-day or between batch 
System suitability 
Stability 
A. Stock Solution Stability 
B. Bench Top Stability 
C. Freeze-Thaw Stability 
D. Short term Stability at -20˚ C 
E. Long Term Stability 
 Recovery studies 
 Matrix Effect 
Linearity 
Calibration (standard) curve is the relationship between 
instrument response and known concentrations of the 
analytes. A calibration curve should be prepared in the same 
biological matrix as the samples in the proposed study by 
spiking the matrix with known concentrations of the 
analytes. The number of standards used in constructing a 
calibration Curve will be a function of the anticipated range 
of analytical values and the nature of the analytes/response 
relationship. 
Precision and Accuracy 
The accuracy of an analytical method describes the 
imminence of mean test results obtained by the method to 
the true value (concentration) of the analytes. Accuracy 
should be measured using a minimum of five determinations 
per concentration. The precision of an analytical method 
describes the nearness of individual measures of an analytes 
when the procedure is applied repeatedly to multiple 
aliquots of a single homogeneous volume of biological 
matrix. Precision be supposed to be measured using a 
minimum of five determinations per concentration. 
Precision is expressed as the coefficient of variation (CV). 
Precision should be demonstrated for the LLOQ, low, 
medium and high QC samples. [20] 
System Suitability: 
System Suitability is the ability of an analytical method to 
differentiate and quantify the analytes in the presence of 
other components in the sample. The selectivity of the 
method was evaluated by analyzing six replicates of plasma 
samples spiked at LLOQ (Lower Limit of Quantification). 
Stability 
Drug stability in a biological fluid is a role of the storage 
conditions, the chemical properties of the drug, the matrix, 
and the container system. Stability evaluation is done to 
show that the concentration of analytes at the time of 
analysis corresponds to the concentration of the analytes at 
the time of sampling. 
A) Stock Solution Stability 
The stability of stock solutions of drug and the internal 
standard should be evaluated at room temperature for at 
least six hours. If the stock solutions are refrigerated or 
frozen for the relevant period, the stability should be 
recognized. After completion of the desired storage time, the 
stability should be tested by comparing the instrument 
response of stored sample with that of freshly prepared 
solutions. 
B) Bench Top Stability 
Bench top stability is to assess the stability of analytes in 
biological fluids over a period of time during which the 
sample are expected to be kept on bench while processing. 
C) Freeze Thaw Stability 
Analytes stability should be determined after three freeze 
and thaw cycles. At least three aliquots at each of the low and 
high concentrations should be stored at the intended storage 
temperature for 24 hours and thawed unaided at room 
temperature. When the sample completely thawed, the 
samples should be refrozen for 12 to 24 hours under the 
same conditions. The freeze–thaw cycle should be repeated 
two more times, and then analyzed on the third cycle. This 
Freeze-Thaw quality control samples were quantified against 
the freshly spiked calibration curve standards of 
concentration range equivalent to that used for the 
calculation of precision and accuracy. 
D) Short Term Temperature Stability 
Three aliquots of each of the low and high concentrations 
should be thawed at room temperature and kept at this 
temperature from 4 to 24 hours (based on the expected 
duration that samples will be maintained at room 
temperature in the intended study) and analyzed. 
E) Long Term Temperature Stability 
The storage time in a long-term stability evaluation should 
exceed the time between the date of first sample collection 
and the date of last sample analysis. Long-term stability 
should be determined by storing at least three aliquots of 
each of the low and high concentrations under the same 
conditions as the study samples. The volume of samples 
should be sufficient for analysis on three separate occasions. 
The concentrations of all the stability samples should be 
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compared to the mean of back-calculated values for the 
standards at the appropriate concentrations from the first 
day of long-term stability testing. 
 Recovery Study 
The recovery of analytes in an assay is the detector response 
obtained from an amount of the analytes added and 
extracted from the biological matrix, compared to the pure 
authentic standard. Recovery pertains to the extraction 
efficiency of an analytical method within the limits of 
variability. Recovery of the analytes need not be 100%, but 
the extent of recovery of an analytes and of the internal 
standard should be consistent, precise, and reproducible. 
Recovery experiments should be performed by comparing 
the analytical results for extracted samples at three 
concentrations (low, medium, and high) with unextracted 
standards that represent 100% recovery. [21-23] 
 Matrix Effect 
Matrix effect is defined as the effect of co-eluting residual 
matrix component of biological sample on the ionization of 
target. There are two types of the matrix effect e.g. absolute 
matrix effect and relative matrix effect. Absolute matrix 
effect is defined as difference between response of equally 
concentrated analyte in solvent and in matrix extracts. Two 
types of absolute matrix effect one is ion suppression which 
is more often observed and other is ion enhancement. 
Relative matrix effect is defined as the variation of absolute 
matrix effect between several lots of same matrix. Matrix 
effect may cause decrease or increase in sensitivity over the 
time, increased baseline, imprecision of result, retention 
time change and chromatographic peak tailing. Some sample 
preparation procedures have been of tremendous 
significance in reducing matrix effect. As demand for assay 
sensitivity rises because of evaluation increase in potent 
drug and which can be detected in low concentration. 
Selection of sample preparation to minimize matrix effect is 
heavily determined by molecular analysis and specimen 
type. Volume of reagent, flow rate, and various protocol 
parameters of matrix reduction should be compatible with 
analysis. In the number of cases, matrix components which 
might cause ionization enhancement or suppression are 
removed during sample cleaning process. Many method 
used for sample clean up most simple method is protein 
precipitation method. Other method used is liquid extraction 
and solid phase extraction method. Matrix effect can be 
caused by organic and inorganic substances present, amines, 
urea, carbohydrates etc. The CV of the IS-normalized matrix 
factor (MF) calculated from the 6 lots of matrix should not be 
greater than 15 %.  This determination should be done at a 
low and at a high level of concentration (maximum of 3 
times the lower limit of quantification (LLOQ) and close to 
the upper limit of quantification (ULOQ). The overall 
coefficient of variation (CV) calculated for the concentration 
should not be greater than 15 %. [24-26] 
Conclusion  
In this review, the basic required concepts and definitions in 
bioanalytical method validation were presented and 
discussed. SPE and LLE are most used sample preparation 
techniques in bioanalysis. Huge progress has been done in 
SPE technology such as new SPE format and new selective 
sorbents. In addition progress in the automated systems for 
sample preparation is expected to meet the need for high 
sample throughput. In addition progress in the automated 
systems for sample preparation is expected to meet the need 
for high sample throughput. Regulatory bioanalysis has an 
essential role in pharmaceutical research and development. 
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